Published in Rev Argent Microbiol on May 03, 1993
Extremely rapid spread of human immunodeficiency virus type 1 BF recombinants in Argentina. J Virol (2006) 0.88
Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates. J Clin Microbiol (1995) 0.87
Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina. PLoS One (2014) 0.85
Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals. AIDS Res Hum Retroviruses (1996) 0.96
Coexistence of subtypes B, F, and as B/F env recombinant of HIV type 1 in Buenos Aires Argentina. AIDS Res Hum Retroviruses (1996) 0.93
HIV infection leads to differential expression of T-cell receptor V beta genes in CD4+ and CD8+ T cells. AIDS (1993) 0.92
Genetic diversity of GBV-C/HGV strains among HIV infected-IVDU and blood donors from Buenos Aires, Argentina. Virus Res (1999) 0.88
HIV-1 viral load: comparative evaluation of three commercially available assays in Argentina. Acta Physiol Pharmacol Ther Latinoam (1998) 0.82
Effects of a new heterocyclic glucocorticoid, deflazacort (DFC), on the functions of lymphocytes from patients with rheumatoid arthritis (RA). Int J Immunopharmacol (1987) 0.81
First report of HIV-2 infection in Argentina. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.80
Humoral response to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Tuber Lung Dis (1992) 0.80
HIV-1 and hepatitis B virus infections in adolescents lodged in security institutes of Buenos Aires. Pediatr AIDS HIV Infect (1996) 0.79
Different integrated and unintegrated HIV-1 DNA after superinfection and cell to cell transmission. Acta Physiol Pharmacol Ther Latinoam (1997) 0.76
HTLV-I/II survey on hemodialysis patients in Buenos Aires. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.76
Role of drug injection in the spread of HIV in Argentina and Brazil. Int J STD AIDS (1993) 0.76
Regression of AIDS-related Kaposi's sarcoma following combined antiretroviral treatment. Rev Argent Microbiol (2001) 0.76
Analysis of the role of xenogeneic antigens in the proliferation of human T cells stimulated with autologous non-T cells and phytohemagglutinin-activated T cells. Cell Immunol (1985) 0.75
Human T cells in cord blood: abnormalities in IA antigens induction by phytohemagglutinin and in autologous mixed lymphocyte reactions. Cell Immunol (1984) 0.75
Detection of antibodies to human immunodeficiency virus type I by using synthetic peptides and time-resolved fluoroimmunoassay (TR-FIA). Eur J Epidemiol (1992) 0.75
Genetic analysis of V3 domain sequences obtained from Uruguayan HIV type 1-infected individuals. AIDS Res Hum Retroviruses (1996) 0.75
Troublesome diagnosis in two children born to HIV-1 infected mothers. Rev Argent Microbiol (1998) 0.75
Retrospective study of children born to HIV-1-infected mothers in a pediatric hospital in Argentina. Pediatr AIDS HIV Infect (1995) 0.75
[Prevalence of HIV-1 infection in viral hepatitis patients with a history of intravenous drug abuse]. Bol Oficina Sanit Panam (1989) 0.75
[Detection of the viral load and its use as a virological marker in the follow-up of HIV-1-positive patients]. Rev Argent Microbiol (1998) 0.75
[Prevalence of anti-HTLV-I antibodies in intravenous drug addicts in Argentina]. Medicina (B Aires) (1989) 0.75
Overt and latent HIV 1 and HTLV-I infection in cohorts of at high risk individuals in Argentina. Mol Cell Probes (1991) 0.75
HIV-1 infection in intravenous drug abusers with clinical manifestations of hepatitis in the city of Buenos Aires. Bull Pan Am Health Organ (1989) 0.75
Diagnosis of perinatally acquired HIV-1 infection using an IgA ELISA test. Pediatr AIDS HIV Infect (1996) 0.75
Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.75
[Molecular characterization of HTLV-II from an intravenous drug addict with AIDS in Argentina]. Rev Argent Microbiol (1997) 0.75
[HIV-1 virus transmission through maternal milk]. Medicina (B Aires) (2000) 0.75
Human immunodeficiency virus bDNA assay for pediatric cases. Rev Argent Microbiol (2000) 0.75
T-lymphocytes phenotype and functions in patients with head and neck cancer. Laryngoscope (1985) 0.75
[Evaluation of indirect immunofluorescence as a supplementary test for the diagnosis of HIV-1 infection]. Rev Argent Microbiol (1998) 0.75
Presence of human T-cell lymphotropic virus types I and II and coinfection with human immunodeficiency virus in different groups at risk in Argentina. J Acquir Immune Defic Syndr (1993) 0.75
Identification of human immunodeficiency virus type 1 subtypes B and F B/F recombinant and dual infection with these subtypes in Argentina. Scand J Infect Dis (1999) 0.75
HTLV-I/II seroprevalence and coinfection with other pathogens in blood donors in Buenos Aires. J Acquir Immune Defic Syndr (1994) 0.75
HIV-1 and HBV infection in street youth lodged in security institutes of Buenos Aires. J Acquir Immune Defic Syndr (1994) 0.75
[Basic and clinical aspects of drug resistance in human immunodeficiency virus type 1 infection]. Rev Argent Microbiol (1996) 0.75
[Esophageal hiatal hernia and cardiocirculatory symptomatology]. Minerva Med (1972) 0.75
High prevalence of HTLV-I infection in Argentinian blood donors: a new HTLV-I-endemic area? J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.75
[Multiple myeloma. Case reports]. Minerva Med (1971) 0.75